Journal of Clinical Medicine (Feb 2022)

A Longitudinal Study of Mitral Regurgitation Detected after Acute Myocardial Infarction

  • Harish Sharma,
  • Mengshi Yuan,
  • Iqra Shakeel,
  • James Hodson,
  • Ashwin Radhakrishnan,
  • Samuel Brown,
  • John May,
  • Kieran O’Connor,
  • Nawal Zia,
  • Sagar N. Doshi,
  • Sandeep S. Hothi,
  • Jonathan N. Townend,
  • Saul G. Myerson,
  • Peter F. Ludman,
  • Richard P. Steeds,
  • M. Adnan Nadir

DOI
https://doi.org/10.3390/jcm11040965
Journal volume & issue
Vol. 11, no. 4
p. 965

Abstract

Read online

Background: Mitral regurgitation (MR) is common following myocardial infarction (MI). However, the subsequent trajectory of MR, and its impact on long-term outcomes are not well understood. This study aimed to examine the change in MR severity and associated clinical outcomes following MI. Methods: Records of patients admitted to a single centre between 2016 and 2017 with acute MI treated by percutaneous coronary intervention (PCI) were retrospectively examined. Results: 294/1000 consecutive patients had MR on baseline (pre-discharge) transthoracic echocardiography (TTE), of whom 126 (mean age: 70.9 ± 11.4 years) had at least one follow-up TTE. At baseline, most patients had mild MR (n = 94; 75%), with n = 30 (24%) moderate and n = 2 (2%) severe MR. Significant improvement in MR was observed at the first follow-up TTE (median 9 months from baseline; interquartile range: 3–23), with 36% having reduced severity, compared to 10% having increased MR severity (p p = 0.003) and lower creatinine clearance (mean: 60 vs. 81 mL/min, p = 0.015). Change in MR severity was significantly associated with prognosis: 16% with improving MR reached the composite endpoint of death or heart failure hospitalisation at 5 years, versus 44% (p = 0.004) with no change, and 59% (p < 0.001) with worsening MR. Conclusions: Of patients with follow-up TTE after MI, MR severity improved from baseline in approximately one-third, was stable in around half, with the remainder having worsening MR. Patients with persistent or worsening MR had worse clinical outcomes than those with improving MR.

Keywords